Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Hydrocortisone, Vitamin C and Thiamine for the Treatment of Septic Shock

NCT03380507 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT03380507
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03380507 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Hydrocortisone, Vitamin C and Thiamine for the Treatment of Septic Shock
Lead sponsor
Hamad Medical Corporation
Phase
Phase 2/3
Overall status
Terminated
Start date
March 17, 2018
Completion date
November 1, 2021
Enrollment
106 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, septic shock